Joint Formulary & PAD

Apomorphine hydrochloride - Parkinson's disease

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Amber
Formulations :
  • Pre-filled syringe
  • Subcutaneous infusion
  • Subcutaneous injection (sc)
Associated Icons :
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Apomorphine hydrochloride
Indication :
Parkinson's disease
Group Name :
Keywords :
PD
Brand Names Include :
Apo-go, Dacepton, Apo-Go POD
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Other Indications

Below are listed other indications that Apomorphine hydrochloride is used to treat.

Committee Recommendations (1)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) have reviewed and agreed the updated apomorphine AMBER shared care document.